Navigation Links
Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents
Date:3/16/2009

s. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of the Company's Specialty Pharmaceutical and Human Genetic Therapies products, as well as the ability to secure and integrate new products for commercialization and/or development; government regulation of the Company's products; the Company's ability to manufacture its products in sufficient quantities to meet demand; the impact of competitive therapies on the Company's products; the Company's ability to register, maintain and enforce patents and other intellectual property rights relating to its products; the Company's ability to obtain and maintain government and other third-party reimbursement for its products; and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Shire Divests Non-Core Product Portfolio to Almirall
4. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
5. David Mott Appointed Non Executive Director at Shire
6. Shire plc: Board Changes
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
10. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
11. Shire Engages Palio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Mosaic Company (NYSE: MOS ) plans to ... and financial tables on Tuesday, January 5, 2010, after ... Exchange. Results will be available on Mosaic,s website ... a conference call with presentation slides on Wednesday, January ... will begin at 11:00 a.m. Eastern Standard Time (10:00 ...
(Date:12/15/2009)... PHILADELPHIA, Dec. 15 The Center ... Advanstar Communications, is pleased to announce the ... Pharmaceutical/Biotech Accounting and Reporting Congress . The ... Philadelphia, on March 16-17, 2010. ,, Over ... professionals have attended this premier event since ...
(Date:12/15/2009)... Dec. 15 Thomson ... ® has become the first drug pipeline database ... outcome information. This highly anticipated new content is ... month. ,, Thomson Pharma ... registries, publications, press releases, conferences, and other sources ...
(Date:12/15/2009)... the launch of several innovative new programs to aid ... current economic climate. The first is aimed at ... services over a period of 6, 12, 18, or ... companies. The second is aimed at more established ... 6 to 12 month period at discounted rates, and ...
Breaking Biology Technology:Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2
... Mass., June 24 Tolerx, Inc., a,biopharmaceutical company ... for the treatment of immune-mediated diseases, announced today,that ... "Fierce 15" list,designating it as one of the ... evaluated hundreds of privately-held firms based on company,vision, ...
... intensifies competition between spine companies, ... June 24 According to Millennium,Research Group,s (MRG,s) ... the spinal fusion market is rife with competitive,movements ... market to over $5.2 billion by 2012., ...
... ET, NEW YORK, June 24 Keryx Biopharmaceuticals,Inc. ... Weiss, the Company,s,Chairman and Chief Executive Officer, is scheduled ... held in New York City., Mr. Weiss, presentation ... ET and will be accessible from the Investor Information ...
Other Biology Technology:Tolerx Named as One of the 'Fierce 15' Biotech Companies of 2008 2Tolerx Named as One of the 'Fierce 15' Biotech Companies of 2008 3Competition Alive in the Global Spine Market 2Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference 2
(Date:12/15/2009)... near future, consumers can look forward to ultra-low ... laptops, PDAs and mobile phones. This is made ... technologies which are critical elements for power optimisation ... systems. , Analog IC design is the key ... To pre-position the nation in advanced analog and ...
(Date:12/15/2009)... mouse is a standard laboratory model organism, but ... techniques to analyze blood and blood-forming tissues in ... compact and easy-to-use laboratory resources from Cold Spring ... Mouse Hematology features step-by-step protocols for the ... bone marrow, and other hematopoietic tissues in the ...
(Date:12/14/2009)... an international team that has used DNA samples from ... of North America,s woolly mammoths and ancient horses. , ... Sciences professor Duane Froese and his colleagues counters an ... and teeth. That analysis concluded that more than half ... disappeared about 13,000 years ago. , In the ...
Breaking Biology News(10 mins):NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3New source of classical techniques for blood-based studies in the laboratory mouse 2Stemedica Requests Pre IND Meeting With FDA 13642 1Stemedica Requests Pre IND Meeting With FDA 13642 2Mesothelioma Resource Center Enters Twitter World 55007 1Mesothelioma Resource Center Enters Twitter World 55007 2Frost 26 Sullivan 3A Medico Legal Implications Related to the Usage of Electronic Health Record 55005 1Frost 26 Sullivan 3A Medico Legal Implications Related to the Usage of Electronic Health Record 55005 2Frost 26 Sullivan 3A Medico Legal Implications Related to the Usage of Electronic Health Record 55005 3Frost 26 Sullivan 3A Medico Legal Implications Related to the Usage of Electronic Health Record 55005 4
... Research Center have, for the first time, induced a ... the first demonstration of "hibernation on demand" in a ... cancer and prevent injury and death from insufficient blood ... essence, temporarily converting mice from warm-blooded to cold-blooded creatures, ...
... In a 12-hour, dual-stage surgery known to be performed ... at the University of Alabama at Birmingham on Tuesday ... surgically removing his pancreas to eliminate constant, severe pain ... of Panama City, Fla., remained anesthetized in the operating ...
... chemists have discovered a new way to sabotage DNA's ... to the development of new anti-cancer drugs and therapies. ... treatment more precisely, rather than directing chemotherapeutic medication or ... Greenberg, a chemistry professor in the university's Zanvyl Krieger ...
Other Biology News: U-M team recovers ancient whale in Egyptian desert 2 U-M team recovers ancient whale in Egyptian desert 3 U-M team recovers ancient whale in Egyptian desert 4 U-M team recovers ancient whale in Egyptian desert 5Rare surgery performed to remove pancreas, prevent diabetes 2
Dnase and Rnase free...
...
... Well BAC Prep; Ideal for ... 1.5ml 2xYT cultures; Provides high-quality ... sequencing for small to large ... which minimizes shearing and improves ...
Hybridization Buffer 3.6 ml...
Biology Products: